![Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates | Antimicrobial Agents and Chemotherapy Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.01647-17/asset/3b2fd81b-c5ec-41cc-8752-24cd24c938ca/assets/graphic/zac0041870100003.jpeg)
Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates | Antimicrobial Agents and Chemotherapy
![Performance of a Divided-Load Intravenous Vancomycin Dosing Strategy for Obese Patients - Tina Harrach Denetclaw, Mark Kevin Yu, Mee Moua, Thomas C. Dowling, Douglas Steinke, 2015 Performance of a Divided-Load Intravenous Vancomycin Dosing Strategy for Obese Patients - Tina Harrach Denetclaw, Mark Kevin Yu, Mee Moua, Thomas C. Dowling, Douglas Steinke, 2015](https://journals.sagepub.com/cms/10.1177/1060028015586423/asset/images/large/10.1177_1060028015586423-fig4.jpeg)
Performance of a Divided-Load Intravenous Vancomycin Dosing Strategy for Obese Patients - Tina Harrach Denetclaw, Mark Kevin Yu, Mee Moua, Thomas C. Dowling, Douglas Steinke, 2015
![The Dissociation of Gefitinib Trough Concentration and Clinical Outcome in NSCLC Patients with EGFR Sensitive Mutations | Scientific Reports The Dissociation of Gefitinib Trough Concentration and Clinical Outcome in NSCLC Patients with EGFR Sensitive Mutations | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep12675/MediaObjects/41598_2015_Article_BFsrep12675_Fig1_HTML.jpg)
The Dissociation of Gefitinib Trough Concentration and Clinical Outcome in NSCLC Patients with EGFR Sensitive Mutations | Scientific Reports
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients | PLOS Neglected Tropical Diseases
![Ustekinumab trough concentration affects clinical and endoscopic outcomes in patients with refractory Crohn's disease: a Chinese real-world study | BMC Gastroenterology | Full Text Ustekinumab trough concentration affects clinical and endoscopic outcomes in patients with refractory Crohn's disease: a Chinese real-world study | BMC Gastroenterology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12876-021-01946-8/MediaObjects/12876_2021_1946_Fig3_HTML.png)
Ustekinumab trough concentration affects clinical and endoscopic outcomes in patients with refractory Crohn's disease: a Chinese real-world study | BMC Gastroenterology | Full Text
![Tacrolimus Dose Optimization Strategy for Refractory Ulcerative Colitis Based on the Cytochrome P450 3A5 Polymorphism Prediction Using Trough Concentration after 24 Hours | Semantic Scholar Tacrolimus Dose Optimization Strategy for Refractory Ulcerative Colitis Based on the Cytochrome P450 3A5 Polymorphism Prediction Using Trough Concentration after 24 Hours | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4f3b6ce2ef6633481db074b70401a929c74fcd46/5-Figure1-1.png)
Tacrolimus Dose Optimization Strategy for Refractory Ulcerative Colitis Based on the Cytochrome P450 3A5 Polymorphism Prediction Using Trough Concentration after 24 Hours | Semantic Scholar
![Comparison of D-dimer values at peak and trough concentrations of direct oral anticoagulants: result of D-dimer testing is not affected by plasma drug concentration - ISTH Congress Abstracts Comparison of D-dimer values at peak and trough concentrations of direct oral anticoagulants: result of D-dimer testing is not affected by plasma drug concentration - ISTH Congress Abstracts](https://abstracts.isth.org/wp-content/uploads/2021/06/311_results_1.jpg)
Comparison of D-dimer values at peak and trough concentrations of direct oral anticoagulants: result of D-dimer testing is not affected by plasma drug concentration - ISTH Congress Abstracts
![The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients - Chen - 2021 - Pharmacology Research & Perspectives - Wiley Online Library The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients - Chen - 2021 - Pharmacology Research & Perspectives - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/924650a5-9eab-40bd-8f94-e7ca1a3cb90b/prp2885-toc-0001-m.jpg?trick=1678023058646)
The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients - Chen - 2021 - Pharmacology Research & Perspectives - Wiley Online Library
![Candidates for area under the concentration–time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients - ScienceDirect Candidates for area under the concentration–time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213716521001880-ga2.jpg)
Candidates for area under the concentration–time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients - ScienceDirect
![Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit - ScienceDirect Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1201971217301303-gr2.jpg)
Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit - ScienceDirect
![CYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure | Infectious Diseases & Immunity CYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure | Infectious Diseases & Immunity](https://mednexus.org/cms/10.1097/ID9.0000000000000036/asset/cd130d80-893e-42fd-9d59-963a59a47752/assets/graphic/2096-9511-02-02-009-f002.png)
CYP2C19 Genotyping Plus Therapeutic Drug Monitoring Dependent Voriconazole Treatment for Invasive Pulmonary Aspergillosis in a Patient with Liver Failure | Infectious Diseases & Immunity
![Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST | SpringerLink Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10147-023-02325-x/MediaObjects/10147_2023_2325_Fig4_HTML.png)